AKTS
Aktis Oncology
$24.21
+$0.32 (+1.34%)Jul 27, 2026
Key metrics
The numbers that frame AKTS today
- Market cap
- $1.29B
- Div yield
- 0%
- Debt / equity
- 0.0
Growth
Revenue and earnings trend for AKTS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AKTS
Is Aktis Oncology a good buy?
Hold. There is not enough rank data to make a clear call.
What is the market capitalization of AKTS?
Aktis Oncology's market capitalization is $1.29B.
Does AKTS stock pay dividends?
Aktis Oncology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AKTS?
Aktis Oncology's Debt / Equity ratio is 0.02.